Search Within

Moneeza Walji

Formats
  1. Meeting Abstract (8)
  2. Journal Article (2)
  3. Research Letter (1)
Groups
  1. Bone Marrow Transplant (11)
  2. Center for Hematologic Malignancies (11)
  3. Department of Medicine (11)
  4. Hematologic Malignancies, Division of (11)
  5. Survivorship Research (11)
  6. Biostatistics Service (9)

More Groups

People
  1. Miguel-Angel Perales (11)
  2. Sergio Giralt (11)
  3. Gunjan Shah (9)
  4. Gilles Salles (8)
  5. Maria Palomba (8)
  6. Michael Scordo (8)

More People

Years
  1. 2025 (2)
  2. 2024 (3)
  3. 2023 (1)
  4. 2022 (5)
Publications
  1. Blood (7)
  2. Bone Marrow Transplantation (1)
  3. British Journal of Haematology (1)
  4. Haematologica (1)
  5. JAMA Oncology (1)
Publishers
  1. American Society of Hematology (7)
  2. American Medical Association (1)
  3. Ferrata Storti Foundation (1)
  4. John Wiley & Sons (1)
  5. Nature Publishing Group (1)

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Barriers to chimeric antigen receptor T-cell therapy
    Research Letter

    Valtis, Y. K.; Chin, K. K.; Nemirovsky, D.; Devlin, S. M.; Yisraeli Salman, M.; Boussi, L.; Cadzin, B.; McLoughlin, C.; Cathcart, E.; Davis, P.; more...
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Predictors and implications of renal injury after CD19 chimeric antigen receptor T-cell therapy
    Journal Article

    Boardman, A. P.; Gutgarts, V.; Flynn, J. R.; Devlin, S. M.; Goldman, A.; Tomas, A. A.; Fein, J. A.; Slingerland, J. B.; Parascondola, A.; Lin, R. J.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • Prospective feasibility trial of pharmacokinetic directed melphalan for lymphoma patients undergoing autologous hematopoietic cell transplantation
    Meeting Abstract

    Hughes, C. F. M.; Lin, A.; Bromberg, M.; Devlin, S. M.; Saldia, A.; Engstler, D. E.; Hanley, D. M.; Aremu, Y.; Donach, M.; Hoover, E.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Barriers to immune effector cell therapy: Rapid disease progression, concern for toxicity, and lack of appropriate trials drive non-receipt after referral at a large academic center
    Meeting Abstract

    Valtis, Y. K.; Chin, K. K.; Yisraeli Salman, M.; Boussi, L.; Cadzin, B.; McLoughlin, C.; Cathcart, E.; Davis, P.; Brooklyn, C.; Goldstein, T.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Atrial arrhythmias following CAR-chimeric antigen receptor T-cell therapy: Incidence, risk factors and biomarker profile
    Journal Article

    Shouval, R.; Goldman, A.; Flynn, J. R.; El-Moghraby, A.; Rehman, M.; Devlin, S. M.; Corona, M.; Landego, I.; Lin, R. J.; Scordo, M.; more...
    British Journal of Haematology (2024)

    Fulltext@MSK | Save
  • A reproducible inflammatory biomarker signature identifies non-Hodgkin lymphoma patients at high risk of CAR-T treatment failure across different cohorts
    Meeting Abstract

    Raj, S.; Perales, M. A.; Fei, T.; Fein, J.; Tomas, A. A.; De LaPuerta, M. C.; Dahi, P.; Danylesko, I.; Epstein-Peterson, Z.; Fried, S.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • Severe persistent cytopenias following CAR T-cell therapy in patients with large B-cell lymphoma
    Meeting Abstract

    De Lapuerta, M. C.; Shouval, R.; Tomas, A. A.; Flynn, J. R.; Devlin, S. M.; Batlevi, C. L.; Fein, J. A.; Giralt, S. A.; Lin, R. J.; Nath, K.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Association of linguistic barriers and survival in allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Walji, M.; Lee, J.; Devlin, S. M.; Gany, F.; Perales, M. A.; Giralt, S. A.; Cho, C.
    Blood (2022)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic cell transplantation in patients with relapsed or refractory acute leukemia
    Meeting Abstract

    Elias, S.; Walji, M.; Brown, S.; Devlin, S. M.; Papadopoulos, E. B.; Jakubowski, A. A.; Ponce, D. M.; Young, J. W.; Giralt, S. A.; Perales, M. A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Predictors and implications of renal injury in large cell lymphoma patients receiving CD19 CAR T cell therapy
    Meeting Abstract

    Boardman, A. P.; Gutgarts, V.; Flynn, J. R.; Devlin, S. M.; Tomas, A. A.; Fein, J. A.; Slingerland, J.; Parascondola, A.; Lin, R. J.; Scordo, M.; more...
    Blood (2022)

    Fulltext@MSK | Save